Fenofibrate, a medication of the fibrate class used to treat abnormal blood lipid levels, was found to reduce COVID-19 severity and mortality.

This finding has the potential to significantly change how Corona patients are being treated and the severity of the disease, the Hebrew University said.

The study, led by Professor Yaakov Nahmias, Director of the Center for Bioengineering at Hebrew University, applied a well-established existing drug to address the buildup of fats in human lung cells caused by the SARS-CoV-2 virus.

Initial lab-based results and new data from 1,500 Israeli Corona patients have been extremely promising and clinical studies are scheduled to begin this week at Barzilai Hospital in Ashkelon, joining other clinical centers across the US, South America and Europe.

The study began in July 2020 when Professor Nahmias demonstrated that the SARS-CoV-2 virus was inhibiting the effective breakdown of fat within the lungs.

His research then identified the efficacy of Fenofibrate (Tricor), an FDA approved drug that has been on the market since 1975 to address this deficiency in Corona patients.

The drug is traditionally designed to address high levels of triglycerides (fats) in the blood. When applied to Corona patients, the study proposes that it will stop the progression of the disease.

"We knew that the system we had developed for Tissue Dynamics provided us with a unique vantage point to understand how the virus operates in the lungs," Nahmias explained.

After discovering the efficacy of the drug in the lab-setting, Nahmias, together with Professor Oren Shiboleth of Ichilov Medical Center in Tel Aviv, and Dr. Sigal Shafram-Tikva at Hadassah Medical Center in Jerusalem, worked to gather data from 1,500 Corona patients who were on a regiment of drugs designed to reduce the fatty buildup in lung cells.

"The results were abundantly clear," the Hebrew University said.

Patients who were taking the drugs to speed up the breakdown of fats were recovering from the Corona-caused lung infections in a matter of days. The evidence further showed that there was zero mortality among these patients.

"We showed that the human lungs responded to the SARS-CoV-2 virus by completely changing their metabolism, causing a major buildup of fats in lung cells. Our findings show that this unhealthy fat buildup is a critical factor in COVID-19 patient's deterioration. Patients taking fibrates that work directly to breakdown fats recovered fast from the disease, while those taking medications that build fats like thiazolidinediones, showed greater lung damage and mortality," Nahmias explained.

According to the research team, applying the use of this established drug, which is widely available, inexpensive and has a proven safety record, could alter the effects of COVID-19 from a devastating disease to a far more manageable form of a respiratory cold.

In the coming days, the team will begin an investigator-led Phase 3a clinical study at Barzilai Hospital, led by Professor Shlomo Maayan, Director of the Department of Infectious Diseases.

"Even as we see the introduction of numerous vaccines intended to reduce the transmission of the disease and protect vulnerable populations, this drug can help the direct treatment of the virus and reduce its severity and mortality. We hope to see the first results of the clinical phase of this study in the coming months," Professor Maayan said. Subscribe for free to Breaking Christian News here

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Devout Jew Decides to Disprove Scripture by Reading the Bible; Is 'Blown Away' by What He Finds

South Dakota Passes Prenatal Development Education Bill

How Is a Free Cuba in the National Interest of the United States?

Trump Forges Alliance With Conservative Latin American Leaders at the 'Shield of the Americas' Summit

[Video] Trump Has Highest Own-Party Approval of Any 21st Century President, CNN Survey Shows

Noem Saga Grows More Bizarre as IG Accuses DHS of Blocking Investigations, Including One Involving Butler

Trump Says Only Iran Deal He Will Accept Is 'Unconditional Surrender'

'Don't Mess With Texas': 'Overwhelming' Push Back on Sharia Law in the Lone Star State

Update on Savannah Guthrie's Plans, Investigation into Nancy's Disappearance: She 'May Already Be Gone'

Austin's Liberal DA Makes Major Call About Officers Who Shot Suspected Terrorist that Killed 3, Injured Over a Dozen

Media Ignore Arrest of 14-Year Illegal Alien with 30 Arrests in Case of Virginia Bus Stop Stabbing Murder

Poll: 57 Percent of Americans Want All Illegal Migrants Sent Home

US Supreme Court Hands Unanimous Victory to Trump Administration on Asylum Cases

Pentagon Releases Identities of 6 US Soldiers Killed in Kuwait: 'They Laid Down Their Lives'

Hegseth: Iran Regime Is 'Toast' as Israel, US Broaden Strikes

Senator Fetterman Joins GOP to Block Iran War Powers Effort

President Trump Replaces Kristi Noem at DHS with Senator Markwayne Mullin

[Watch] After Fleeing the Regime Decades Ago, She Fights for a Free Iran and Exposes 'Islamic Radicalism'

'Madam President' Melania Trump Becomes First World Leader's Spouse to Chair UN Security Council

Former Indiana Music Teacher Wins Settlement after Being Forced to Resign for Not Using Trans Pronouns